Results 171 to 180 of about 145,320 (184)

Anti-PLA2R Antibody Levels and Treatment Response in Primary Membranous Nephropathy (MN)

Journal of the American Society of Nephrology, 2023
Anne-Els van de Logt, Coralien Vink-van Setten, Jack F. Wetzels   +2 more
openaire   +1 more source

Clinical Observation of Serum Anti-PLA2R Antibody Levels in the Treatment of Idiopathic Membranous Nephropathy with Rituximab

Journal of Clinical and Nursing Research
Objective: To investigate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy with varying levels of serum phospholipase A2 receptor antibodies. Methods: A total of 137 patients with idiopathic membranous nephropathy admitted to Beijing Sixth Hospital were selected. Based on their blood PLA2R antibody levels before rituximab
openaire   +1 more source

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy

Kidney International Reports, 2023
Omar Ragy, Anirudh Rao, Durga A K Kanigicherla   +2 more
exaly  

“Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies”

Seminars in Arthritis and Rheumatism
Ivana Capuano, Pasquale Buonanno, Eleonora Riccio, Maria Luigia Sellitti, Antonio Pisani   +4 more
openaire   +3 more sources

Anti-PLA2R Antibody Trajectories for Predicting Prognosis in Patients with PLA2R-Associated Membranous Nephropathy.

American journal of nephrology
Phospholipase A2 receptor (PLA2R) is the major autoantigen in membranous nephropathy (MN); however, the trajectories of anti-PLA2R antibodies and their prognostic implications remain unclear.In this retrospective cohort study, we analyzed 1,528 patients with PLA2R-associated membranous nephropathy (2011-2022), each with at least three serial ...
Siwen, Gong, Dacheng, Chen, Feng, Xu, Zhe, Li, Aijuan, Li, Zhihong, Liu, Mengyao, Zeng   +6 more
openaire   +1 more source

The High-Throughput Approach Identifies Compounds that Block PLA2R and Anti-PLA2R Antibody Interaction

Journal of the American Society of Nephrology, 2023
Zixin Feng, Fusheng Guo, Zhao Cui
openaire   +1 more source

The role of anti-PLA2R antibody in membranous nephropathy diagnosis

Clinica Chimica Acta
M. Kurti, E. Kurti, S. Mumajesi, N. Spahia   +3 more
openaire   +1 more source

Anti-PLA2R Antibody Development During NELL1-Associated Membranous Glomerulonephritis Treatment: A Case Report

Kidney Medicine, 2023
Dan Inoue, Takahiro Uchida, Kentaro Sugisaki   +2 more
exaly  

Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients

Clinica Chimica Acta, 2018
Chaoqun Ma, Ju Liu, Xianglei Kong
exaly  

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy

Medicine (United States), 2017
Lu Pang, Haixia Li, Dan Yu
exaly